Drugmaker
“Legislators were forced to make the difficult policy choice—that in an emergency, the national interest is best served by the rapid development and deployment of life-saving vaccines without the looming threat of litigation,” Robert Reeves Anderson, an Arnold & Porter Kaye Scholer partner representing AstraZeneca, argued Wednesday before US Court of Appeals for the Tenth Circuit judges.
Brianne Dressen sued ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
